Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04125940 · ClinicalTrials.gov registry record · NA
Blood Nitrate/Nitrite Concentrations Following Acute Ingestion of Resync in Men and Women
A NA study, sponsored by University of Memphis.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04125940 is a NA study that has completed, run by University of Memphis. The registered enrollment target is 20 participants.
The verdict
NCT04125940, a NA study, has completed, sponsored by University of Memphis.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study evaluates acute ingestion of the dietary supplement Resync on blood nitrate/nitrite concentrations in a sample of men and women. This will be a crossover trial in which participants take all 4 conditions: 1) 7.5g Resync, 2) 15g Resync, 3) 20g Resync+collagen, 4) placebo.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Resync
- DIETARY_SUPPLEMENT Resync + Collagen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-10-14 |
| Est. Completion | 2019-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04125940
The ClinicalTrials.gov registry entry for NCT04125940 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Memphis, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04125940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04125940 about?
NCT04125940 is a clinical study titled "Blood Nitrate/Nitrite Concentrations Following Acute Ingestion of Resync in Men and Women". This study evaluates acute ingestion of the dietary supplement Resync on blood nitrate/nitrite concentrations in a sample of men and women. This will be a crossover trial in which participants take all 4 conditions: 1) 7.5g Resync, 2) 15g Resync, 3) 20g Resync+collagen, 4) placebo.
What is the current status of trial NCT04125940?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-10-14. Estimated completion is 2019-12-30.
What interventions are being tested in trial NCT04125940?
The interventions under investigation include: Placebo (OTHER), Resync (DIETARY_SUPPLEMENT), Resync + Collagen (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04125940?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.